| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.00095 | 1 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.00059 | 1 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.00067 | 1 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.00066 | 1 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.00067 | 1 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.00049 | 1 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.00058 | 1 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.00039 | 1 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.00031 | 1 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.00032 | 1 |